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Abstract Phosphatidylinositol (PI) 3,4-P2 is a phosphoinositide
that has been shown to be important for signal transduction in
growth factor stimulation. We have produced monoclonal
antibodies specific for PI 3,4-P2, which were able to detect PI
3,4-P2 generated in 293T cells treated with H2O2, or in MKN45/
BD110 cells expressing activated PI 3-kinase in immunostaining.
Prolonged treatment with 0.05% Tween 20 resulted in detection
of staining not only at the plasma membrane, but also at the
nuclear surface, indicating that 3P-phosphorylated phosphoinosi-
tides can be generated and function in the nucleus.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Involvement of phosphatidylinositol (PI) 3-kinase in signal
transduction is well known. PI 3-kinase can be activated by
appropriate stimuli to yield PI 3,4,5-P3 from PI 4,5-P2 [1,2].
PI 3-kinase appears to be multifunctional. Use of selective
inhibitors, dominant-negative mutants, constitutively active
mutants and other reagents showed that PI 3-kinase is in-
volved, for example, in signal transduction to the nucleus
from growth factor receptors, in vesicle transport and in cy-
toskeletal rearrangement. There are varieties of activation
mechanisms of PI 3-kinase. It can be activated by binding
to autophosphorylated growth factor receptors, other proteins
phosphorylated on tyrosine residues such as IRS1 or Gab1,
small G proteins such as Ras, or LQ subunits of trimolecular G
proteins [2,3]. These lines of evidence suggest that PI 3-kinase
can act in various parts of cells which are targeted by these PI
3-kinase-binding molecules. However, it has not been clear
where PI 3-kinase is activated because of the absence of ap-
propriate probes for detecting its products. Recent work with
PI 3,4,5-P3-binding proteins has shown that PI 3-kinase is
activated on the plasma membrane [4^6]. However, these sig-
nals might re£ect the unique roles of each PI 3,4,5-P3-binding
protein, not showing the entire picture of the activation pat-
terns of PI 3-kinase.
PI 3,4-P2 can be produced by dephosphorylation of PI
3,4,5-P3 or by phosphorylation of PI 4-P [7]. However, in
many cases, elevation of the PI 3,4-P2 level after growth factor
stimulation appears to be due to activation of PI 3-kinase
followed by dephosphorylation of PI 3,4,5-P3 [8,9]. PI 3,4-
P2 has been shown to activate Akt/PKB by binding to its
PH domain. Signaling of Akt/PKB has been shown to be
important for the survival of cells, suggesting that PI 3,4-P2
is an important second messenger for cell survival [10,11]. PH
domains have been shown to bind to phosphoinositides. Some
of them were shown to bind to PI 3,4,5-P3 speci¢cally, thus
being able to provide probes for PI 3,4,5-P3. However, there
are no PH domains found which bind only to PI 3,4-P2. For
this reason, no attempt has been made to detect PI 3,4-P2 in
cells.
We have identi¢ed PIP3BP as a nuclear PI 3,4,5-P3-binding
protein [12]. Because a considerable level of PI 4,5-P2 is de-
tected in nuclei, it is likely that PI 3,4,5-P3 is generated in the
nucleus. Indeed, we suggested the generation of PI 3,4,5-P3 in
the nuclear fraction of the cells treated with H2O2 or with
growth factors by using biochemical methods [13]. However,
further evidence should be provided to prove that PI 3,4,5-P3
is really generated in the nucleus. Here, we demonstrate the
production of PI 3,4-P2-speci¢c monoclonal antibodies that
stain PI 3,4-P2 generated in cells, and we show that 3P-
phosphorylated phosphoinositides can be generated at the nu-
clear surface.
2. Materials and methods
2.1. Cell lines used in this study
Mouse SP2/0 cells were used for the production of anti-PI 3,4-P2
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antibodies [14]. 293T and MKN45/BD110 cells were cultured in Dul-
becco’s modi¢ed minimal essential medium (DMEM) supplemented
with 10% calf serum [15,16].
2.2. Production of PI 3,4-P2-speci¢c antibodies
Salmonella minnesota cells washed twice with distilled water, twice
with acetone and once with diethyl ether were dried in vacuo. After
removal of ketodeoxyoctonates-linked oligosaccharides by heating in
1% aqueous acetic acid solution, 50 Wg of the Salmonella were coated
with 10 Wg of PI 3,4-P2 and were injected into mice via the lateral tail
veins [17]. One to eight weeks after the ¢rst immunization, the mice
received a booster injection, and fusion with SP2/0 was performed
3 days later [17].
Hybridoma supernatants were screened for antibodies against PI
3,4-P2 by a liposome lysis assay.
2.3. Liposome lysis assay
A complement-dependent liposome lysis assay was performed ac-
cording to the method of Miyazawa et al. with a slight modi¢cation
[17]. Brie£y, a dried lipid ¢lm containing 1.0 mM dimyristoyl-phos-
phatidylcholine (DMPC), 1.2 mM cholesterol, 2.2 mM diethylphos-
phate and 0.022 mM PI 3,4-P2 or other phospholipids was dispersed
in 0.25 ml of marker solution containing 7.5 mM calcein. After wash-
ing with isotonic salt solution, the resulting liposomes were reacted
with monoclonal antibodies in the presence of guinea pig complement
to release internally trapped calcein. Dilution of calcein by its release
from liposomes results in enhanced £uorescence, which was measured
for quanti¢cation of liposome lysis. Fluorescence given by bovine
serum albumin instead of monoclonal antibodies was used as a 0%
lysis value. For a 100% lysis value, liposomes were destroyed by
freezing and thawing. In some instances, rabbit anti-mouse IgG
(heavy chain+light chain) was used as a second antibody to enhance
the reaction.
2.4. Dot-blot analysis
Phospholipids were dissolved in an ethanol solution containing 10
WM DMPC and spotted on a polyvinylidene di£uoride (PVDF) mem-
brane (Millipore Co., Milford, MA, USA). The membrane was incu-
bated with 3% bovine serum albumin in HEPES-bu¡ered saline (pH
7.4). After washing with Tris-bu¡ered saline (TBS), the membrane
was incubated with anti-PI 3,4-P2 antibodies, and then with alkaline
phosphatase-conjugated goat anti-mouse IgG3 or anti-mouse IgG and
IgM. After washing with TBS, the signals were visualized with bromo-
chloro-indoyl-phosphate (BCIP)/nitro blue tetrazolium (NBT) phos-
phate substrate.
2.5. Activation of PI 3-kinase
For activation of PI 3-kinase in 293T cells, the cells were treated
with 10 mM H2O2 for 1, 3, 5 and 10 min. Under these conditions, PI
3-kinase is activated dramatically [18]. The production of PI 3,4-P2
was analyzed as described previously [19]. Constitutively active PI 3-
kinase (BD110) gene was induced in MKN45 cells carrying the PI 3-
kinase gene in a silent form. The cells were infected with an adenovi-
rus encoding the Cre recombinase AxCANCre, at a multiplicity of
infection of 20, and incubated at 37‡C to induce the expression of
BD110 by the Cre-loxP recombination system [16].
2.6. Staining of PI 3,4-P2 by speci¢c antibodies
For immuno£uorescence studies, cells were grown on glass cover-
slips coated with poly-L-lysine. They were ¢xed for 20 min in phos-
phate-bu¡ered saline (PBS) containing 10% formaldehyde and per-
meabilized with 0.05% Tween 20 in PBS for 30 min or 2 h. After
washing with PBS three times, a blocking reaction was carried out
with DMEM containing 10% calf serum at room temperature for 30
min. The glass coverslips were incubated with culture supernatants of
the hybridomas containing 50^100 Wg/ml immunoglobulins for 2 h,
washed in PBS three times, and then incubated with FITC-labeled
anti-mouse IgG for 2 h. In some cases, the culture supernatants
were preincubated with micelles containing 1 mol% of PI 3,4-P2 or
PI 4,5-P2 in phosphatidylcholine (PC), which were produced by dis-
persing the dimethylsulfoxide solution of the lipids into 100 volumes
of PBS. After washing with PBS three times, they were observed by
£uorescence microscopy or with the CELLscan System from Scana-
lytics (Billerica, MA, USA) equipped with a Photometric CCD cam-
era, a piezoelectric Z-axis focus device, and a computer-controlled
excitation light shutter.
3. Results
3.1. Speci¢city of anti-PI 3,4-P2 antibodies
A series of monoclonal antibodies reactive with PI 3,4-P2
was established (Table 1). To determine the speci¢city of the
antibodies, we tested liposomes containing various phospho-
lipids. As shown in Table 1 and Fig. 1A, the monoclonal
antibodies were reactive with PIP3 or PI 4,5-P2 except for
one; however, their a⁄nity for PI 3,4-P2 was much higher
than that for these lipids. Phospholipids other than PI 3,4-
P2 required too much concentration of antibodies to deduce
EC50.
The liposome lysis assay is applicable only to lipids. To test
water-soluble compounds such as Ins 1,3,4-P3, which has a
structure similar to the head group of PI 3,4-P2, we estab-
lished a liposome competition assay. The antibodies were in-
cubated with various concentrations of compounds for testing
prior to the liposome lysis assay of PI 3,4-P2. As shown in
Fig. 1B, preincubation with PI 3,4-P2 abolished the liposome
lysis reaction, suggesting that this assay was successfully done.
Ins 1,3,4-P3, Ins 1,4,5-P3 or Ins 1,3,4,5-P4 was not e¡ective in
blocking the liposome lysis, suggesting that these compounds
did not react with the antibodies. To con¢rm this further, we
performed dot-blot analysis with phospholipids. The phos-
pholipids were mixed with PC, which did not react with the
antibodies, and were blotted onto a PVDF membrane and
tested for their reactivity with the antibodies. As shown in
Fig. 1C, these antibodies showed a much higher reactivity
with PI 3,4-P2 than with the other lipids in this assay.
3.2. Staining of PI 3,4-P2 in 293T cells
To visualize the formation of PI 3,4-P2, we used 293T cells
Table 1
Summary of anti-PI 3,4-P2 monoclonal antibodies used in this study
Mab Isotype Liposome lysis assay using various lipidsa
(Mab concentration required for 50% liposome lysis (WM))
Inhibition of liposome lysis by various competitorsb
(competitor concentration required for 50% inhibition
of liposome lysis (WM))
PC PE PS PA PI PI 4-P PI 4,5-P2 PI 3,4-P2 PIP3 PI 3,4-P2 I 1,3,4-P3 I 1,4,5-P3 I 1,3,4,5-P4 IP6
8C2 IgG3 ^ ^ ^ ^ ^ ^ ^ 6 ^ 16 ^ ^ ^ ^
#10 IgG2a ^ ^ ^ ^ ^ ^ 1 600 1 32 000 63 ^ ^ ^ ^
#14 IgG3 ^ ^ ^ ^ ^ ^ 3 200 6 3 200 250 ^ ^ ^ ^
#18 IgG3 ^ ^ ^ ^ ^ ^ 160 6 1 600 10 ^ ^ ^ ^
aThe liposome lysis assay was done with PC used as a carrier. Mab concentrations required for 50% lysis of liposomes carrying various lipids
(1 M%) are shown. ‘^’ indicates no e¡ect with 10 mg/ml of the Mabs. ‘PC’ means that no other lipids were added to the liposome.
bVarious competitors were added to the lysis reaction of the liposomes carrying PI 3,4-P2. Competitor concentrations required for 50% inhibi-
tion of the liposome lysis are shown. ‘^’ indicates no e¡ect with 10 mM of the competitors.
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treated with H2O2. After superactivation of PI 3-kinase, a
great accumulation of PI 3,4-P2 was observed, probably due
to the absence of activation of PI 3,4-P2-metabolizing enzyme
in these cells [13,18] (Fig. 2A). Elevation of the PI 3,4,5-P3
level was observed prior to that of PI 3,4-P2. After ¢xation
with formaldehyde, the membrane structure of these cells was
permeabilized with Tween 20. PI 3,4-P2 was stained with the
monoclonal antibody 8C2 and a second antibody conjugated
with FITC. Strong staining of PI 3,4-P2 was observed at the
plasma membrane 3 or 10 min after H2O2 treatment. The time
course of PI 3,4-P2 staining was similar to the PI 3,4-P2 levels
detected by high performance liquid chromatography analysis
(Fig. 2B). Another antibody, #10, gave similar results.
To rule out the possibility that this staining was due to a
non-speci¢c interaction of the antibody with substances other
than PI 3,4-P2, we performed a competition assay with phos-
pholipids. As shown in Fig. 2C, the presence of micelles con-
taining PI 3,4-P2 abolished this staining, whereas that contain-
ing PI 4,5-P2 or control micelles showed no e¡ects on the
staining, suggesting that the staining was speci¢c for PI 3,4-
P2. Further evidence was provided by an experiment using
wortmannin, a PI 3-kinase inhibitor (Fig. 2B). The staining
was completely inhibited by treatment with wortmannin.
These lines of evidence indicate that the staining by the anti-
bodies indeed re£ects the positions of PI 3,4-P2.
3.3. PI 3,4-P2 is generated at the nuclear membrane as well as
in the plasma membrane
We previously showed using a biochemical method that PI
3,4,5-P3 is generated in the nucleus [13]. Because the staining
of the plasma membrane may be strong, it was possible that
the staining at the nucleus would not be detectable in the
presence of the high background of the £uorescence of the
membrane. We, therefore, used a CELLscan system to ana-
lyze the cells.
We utilized this system on MKN45/BD110 cells. These cells
express an activated PI 3-kinase, BD110, upon introduction of
Cre recombinase by an adenovirus vector. They lose cell^cell
contact and show enhanced secretion of mucinous compounds
after induction of PI 3-kinase. We used these cells for detec-
tion of PI 3,4-P2. As shown in Fig. 3A, the cells became
rounded after infection with the AxCANCre virus. These
round cells were stained well with the antibody, whereas those
which did not show a round morphology, escaping from in-
fection by the virus, were not stained, suggesting that the
staining was due to the expression of BD110 (Fig. 3A). Care-
ful examination of these cells revealed that staining was ob-
served not only in the plasma membrane, but also on the
nuclear surface (Fig. 3B). This staining was not seen in con-
trol cells (data not shown). Treatment of the cells with wort-
Fig. 2. A: 293T cells labeled with 32P-orthophosphate were stimu-
lated with 10 mM H2O2, and the production of PI 3,4-P2 was ana-
lyzed. The levels of PI 3,4-P2 are shown as percentage of the total
lipids. B: 293T cells stimulated with H2O2 were ¢xed and stained
with monoclonal antibody 8C2. In one experiment, 100 nM wort-
mannin was added 30 min prior to stimulation of the cells (right
panel). C: Monoclonal antibody 8C2 was preincubated with the
phospholipids (50 WM) indicated in the ¢gure prior to immunostain-
ing. Then 293T cells treated with H2O2 for 5 min were stained with
the antibody.
Fig. 1. A: Liposome lysis assay of the monoclonal antibodies used.
Lysis of liposomes carrying various phosphoinositides shown on the
right side with di¡erent concentrations of monoclonal antibodies (¢-
nal concentration) is shown. This ¢gure shows concentration of
monoclonal antibodies required for the liposome lysis. A second
antibody was used for the assay of monoclonal antibody #10. B:
Various inositol phosphates shown on the right side were added as
competitors to the liposome lysis assay of PI 3,4-P2 in A. The com-
petitor concentration is shown as a ¢nal concentration. C: Various
lipids were blotted on a PVDF membrane with PC as a carrier. The
membrane was probed with the monoclonal antibodies, and the sig-
nals were visualized with anti-mouse IgG conjugated with alkaline
phosphatase and a BCIP/NBT phosphate substrate system. The
amounts of lipids are shown in mol quantities.
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mannin blocked the staining, con¢rming that the antigen is
produced by PI 3-kinase (Fig. 3B).
293T cells were also used for detection of nuclear PI 3,4-P2.
In this case, 30 min treatment with Tween 20 did not allow
the detection of nuclear PI 3,4-P2 ; however, prolongation of
the treatment time enabled us to detect nuclear PI 3,4-P2,
although the staining of the plasma membrane was reduced
somewhat (Fig. 3C). Wortmannin treatment abolished the
staining, con¢rming that the signal depends on activation of
PI 3-kinase (data not shown). This indicates that stronger
detergent treatment was required for the antibodies to reach
the nucleus in these cells. Treatment with 10 mM H2O2 is an
arti¢cial condition; however, these observations may still re-
£ect cell responses after a physiologic activation of PI 3-kinase
to some extent. Taken together, these results suggest that 3P-
phosphorylated phosphoinositides are generated at the nu-
clear surface.
4. Discussion
In this paper, we describe the production of monoclonal
antibodies speci¢c for PI 3,4-P2, which can be used for immu-
nostaining. The staining was shown to be speci¢c because it
was abolished by a PI 3-kinase inhibitor, wortmannin, and by
the presence of PI 3,4-P2 as a competitor. Staining was also
detected in cells expressing activated PI 3-kinase. Although
the systems used in this study were arti¢cially inducing super-
activation of PI 3-kinase, the results shown here open the new
possibility that signaling lipid molecules can be visualized by
staining with antibodies. Unfortunately, our system was not
sensitive enough to detect PI 3,4-P2 under physiologic condi-
tions; however, this can be improved by the use of antibodies
with greater a⁄nity for PI 3,4-P2 or by amplifying the signals
by use of appropriate second antibodies.
We previously reported that PIP3BP, a PIP3-binding pro-
tein, is located in the nucleus and that it can be exported from
the nucleus after expression of activated PI 3-kinase [13]. Con-
sistent with this, generation of PIP3 was detected in the nu-
cleus by biochemical methods. However, the nuclear fraction
can include endoplasmic reticulum attached to the nuclear
membrane, suggesting that con¢rmation by other methods is
needed. Our staining results reported in this paper clearly
show that PI 3,4-P2, which may arise from PI 3,4,5-P3, is
present in the nuclear membrane, supporting the idea that
PI 3,4 5-P3 is generated in the nucleus and that PI 3,4,5-P3-
binding proteins such as PIP3BP can function as PIP3-binding
proteins in the nucleus.
PI 3-kinase has been suggested to play a role in vesicle
transport. According to this hypothesis, PI 3,4-P2 should be
detected in other membranes such as the endoplasmic reticu-
lum or Golgi apparatus. However, we failed to detect such
staining by our method. This can be due to the method we
used for preparation of samples. Treatment with Tween 20 is
required for detection of the staining. Other detergents were
not e¡ective for staining. This suggests that a delicate condi-
tion is required for staining of membrane structures other
than the nuclear membrane and plasma membrane, and that
they are destroyed by the Tween 20 treatment in this study.
Although staining of the nuclear structure was observed in
this study, it is not clear whether PI 3,4-P2 is present inside
the nucleus. Strong detergent treatment is required to permea-
bilize the nuclear membrane, which would destroy all other
membrane structures. Further studies on the conditions of
¢xation may be required for the detection of the whole picture
of PI 3,4-P2.
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